![Kenneth Stauderman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Stauderman
Gründer bei
CALCIMEDICA, INC.
Vermögen: 10 575 $ am 31.05.2026
Profil
Kenneth A. Stauderman is the founder of CalciMedica Subsidiary, Inc., founded in 2006, where the title held is Chief Scientific Officer.
Dr. Stauderman is the founder of CalciMedica, Inc., founded in 2007, where the title held is Chief Scientific Officer.
Former jobs include Director-Olecular & Cell Biology at Sibia Neurosciences, Inc. from 1994 to 2000; Executive Director-Biology & Lead Discovery at TorreyPines Therapeutics, Inc. from 2000 to 2007; Senior Scientist at Sanofi-Aventis U.S.
LLC from 1986 to 1994; and Senior Scientist at Marion Merrell Dow Pharmaceutical, Inc. Education includes undergraduate studies at the University of Virginia and a doctorate from Texas University of Health Center at San Antonio.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CALCIMEDICA, INC. 0,08 % | 28.07.2025 | 12 944 ( 0,08 % ) | 10 575 $ | 31.05.2026 |
Aktive Positionen von Kenneth Stauderman
| Unternehmen | Position | Beginn |
|---|---|---|
| CALCIMEDICA, INC. | Gründer | 01.01.2007 |
CalciMedica Subsidiary, Inc.
 CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Gründer | 11.08.2009 |
Ehemalige bekannte Positionen von Kenneth Stauderman
| Unternehmen | Position | Ende |
|---|---|---|
TorreyPines Therapeutics, Inc.
 TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Corporate Officer/Principal | 01.01.2007 |
Sibia Neurosciences, Inc.
 Sibia Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule therapeutics for disorders of the nervous system | Corporate Officer/Principal | 01.01.2000 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1994 |
Marion Merrell Dow Pharmaceutical, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Kenneth Stauderman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
37
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Sibia Neurosciences, Inc.
Sibia Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule therapeutics for disorders of the nervous system | Health Technology |
CalciMedica Subsidiary, Inc.
CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Health Technology |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
Texas University of Health Center at San Antonio
 Texas University of Health Center at San Antonio Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marion Merrell Dow Pharmaceutical, Inc. | |
CalciMedica, Inc.
 CalciMedica, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
